• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

1-(Pyridin-4-yl)homopiperazine Dihydrochloride: A Comprehensive Overview

The compound 1-(Pyridin-4-yl)homopiperazine Dihydrochloride (CAS No. 851292-41-6) is a fascinating molecule with significant potential in the field of pharmacology and drug discovery. This compound belongs to the class of homopiperazines, which are known for their structural versatility and biological activity. The integration of a pyridine ring into the homopiperazine framework introduces unique electronic and steric properties, making it a valuable compound for exploring novel therapeutic agents.

Homopiperazines are a subclass of piperazines, characterized by the presence of a six-membered ring with two nitrogen atoms at positions 1 and 4. The substitution of a pyridine group at the 4-position of the homopiperazine ring in 1-(Pyridin-4-yl)homopiperazine Dihydrochloride imparts additional aromaticity and conjugation, enhancing its stability and reactivity. This structural feature also facilitates interactions with biological targets, such as enzymes and receptors, making it a promising candidate for drug development.

Recent studies have highlighted the potential of 1-(Pyridin-4-yl)homopiperazine Dihydrochloride in modulating various biological pathways. For instance, researchers have explored its role as a ligand for G-protein coupled receptors (GPCRs), which are critical targets in treating conditions such as hypertension, inflammation, and neurodegenerative diseases. The compound's ability to bind to these receptors with high affinity suggests its potential as a lead compound for developing selective agonists or antagonists.

In addition to its receptor-binding properties, 1-(Pyridin-4-yl)homopiperazine Dihydrochloride has shown promise in enzyme inhibition studies. Its structural features allow it to act as a competitive inhibitor of certain proteases and kinases, which are implicated in cancer progression and immune disorders. This dual functionality underscores its versatility as a chemical tool for exploring diverse biological systems.

The synthesis of 1-(Pyridin-4-yl)homopiperazine Dihydrochloride involves a multi-step process that combines organic synthesis techniques with advanced purification methods. The reaction typically begins with the preparation of the homopiperazine core, followed by substitution at the 4-position with a pyridine moiety. The final step involves protonation to form the dihydrochloride salt, ensuring optimal solubility and stability for subsequent biological assays.

From an analytical standpoint, 1-(Pyridin-4-yl)homopiperazine Dihydrochloride has been thoroughly characterized using modern spectroscopic techniques such as NMR, IR, and mass spectrometry. These analyses confirm its molecular structure and purity, providing a solid foundation for further research. Additionally, computational modeling studies have been conducted to predict its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), which are critical for drug development.

Looking ahead, the exploration of 1-(Pyridin-4-yl)homopiperazine Dihydrochloride is expected to expand into preclinical studies to evaluate its efficacy and safety profiles. Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate its progression toward clinical trials. The compound's unique combination of structural features and biological activities positions it as a key player in the ongoing quest for innovative therapeutic solutions.

• 69008-71-5(4-(N,N-Dibutylamino)pyridine)
• 30198-93-7(4-(4-pyridinyl)-1-Piperazineethanamine)
• 86673-46-3(Piperazine,1-methyl-4-(4-pyridinyl)-)
• 14549-61-2(Piperazine,1-phenyl-4-(4-pyridinyl)-)
• 796038-28-3(INDEX NAME NOT YET ASSIGNED)
• 194853-82-2(1-(pyridin-4-yl)-1,4-diazepane)
• 1008-91-9(1-(pyridin-4-yl)piperazine)
• 1181375-92-7(1-(Pyridin-4-yl)pyrrolidin-3-amine)
• 69008-70-4(N,N-Dipropylpyridin-4-Amine)
• 914289-54-6(4-Pyridinamine, N-[2-(1-pyrrolidinyl)ethyl]-)